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Abstract: When the SARS-CoV-2 pandemic started,[1] science 
came to the immediate attention of the broad public. People 
and politicians were hanging on every word of medical doctors, 
virologists, molecular biologists, data scientists and many others 
in the hope of finding other protective measures than those used 
for centuries such as basic hygiene, distance, or quarantine. 
Here, at the Institute of Chemistry and Biotechnology at the 
Zurich University of Applied Sciences (ZHAW) we were also 
willing to provide scientific solutions to overcome the pandemic. 
Together with our partners from industry, we contributed to the 
development of a Swiss vaccine, are working on filters for active 
ventilated full protective suits and are developing tests to show 
the efficacy and safety of an active antiviral textile that allows 
controlled virus inactivation through an electrochemical reaction 
by applying a small current. 
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Development of an Upstream Production Process for 
a VLP-based Human Vaccine against SARS-CoV-2
The availability of an effective and safe vaccine to prevent 
SARS-CoV-2 provides a solution to overcome the current 
pandemic. The first two approved vaccines are BNT 162b2 
from BioNTech/Pfizer and mRNA-1273 from Moderna. More 
than 50 other candidates are in phase I, II or III clinical trials, 
according to ClinicalTrials.gov and the WHO. In addition to 
mRNA-based vaccines, the main candidates are inactivated 
virus, non-replicating viral vector, protein subunit and virus-
like particle (VLP)-based vaccines. A promising approach 
for rapid and scalable SARS-CoV-2 VLP production is the 
expression of viral protein in Escherichia coli, which was 
investigated on behalf of Saiba Biotech. The two subtasks 
to be realized included production clone optimization and 
reproducible production of VLPs in stirred bioreactor systems 
with working volumes of 250 ml and 30 l.
Protein Expression for Generation of a Vaccine 
Candidate against SARS-CoV-2†
SARS-CoV-2 binds to the host receptor ACE2 via the receptor 
binding domain (RBD) of the spike glycoprotein. The RBD of 
SARS-CoV-2 has a length of 194 amino acids, is glycosylated and 
contains disulfide bonds. The RBD contains antigenic epitopes 
and can be used as a subunit vaccine candidate.[2] 
Two gene cassettes each under the control of the T7 promoter 
integrated into a pETvector (Merck Millipore) for expression in 
E. coli were obtained from Saiba Biotech. The gene cassettes 
encode for two proteins able to assemble into VLPs. The two 
proteins are composed of a short peptide of RBD fused to the coat 
protein of the cucumber mosaic virus, containing a small fragment 
of the tetanus neurotoxin representing a universal T cell epitope, 
and of the structural capsid protein from the cucumber mosaic 
virus, respectively. VLPs derived from cucumber mosaic virus 
displaying RBD were immunogenic and generated antibodies 
in mice, which were able to block the binding of lentiviral 
particles pseudotyped with the spike glycoprotein to Human 
Embryonic Kidney cells expressing ACE2 at their surface.[3] 
The two proteins used for production of VLPs were expressed 
in different E. coli strains. The following E. coli strains were 
used: BL21(DE3), BL21(DE3) transformed with the plasmid 
pGro7, ClearColi(DE3), C2566, Origami 2(DE3), OverExpress 
C41(DE3), Rosetta-gami 2(DE3), Tuner(DE3). The different 
strains used for expression under various growth conditions 
should minimize the formation of inclusion bodies and should 
enhance the formation of soluble protein product. The most 
soluble protein of 24.6 kDa and 35.3 kDa was produced in E. 
coli Tuner(DE3) (Merck Millipore, Sigma-Aldrich 70623) using 
sequence-optimized sequences and 2-YT broth for cultivation.
Controlled and Scalable Upstream Production Process 
for SARS-CoV-2 VLPs‡
The upstream production process consists of a growth phase 
and a production phase. The latter serves to express the target 
protein and is initiated by the addition of induction agents such 
as isopropyl β-d-1-thiogalactopyranoside (IPTG). Establishing 
scalable VLP production required screening studies and the 
design of an experiment method at ml scale to determine the 
most suitable culture media and process-specific parameters 
(optimal concentration of IPTG, induction time, growth and 
production temperature, initial cell or optical density, OD) to 
guarantee the desired quantity and solubility of the VLPs. For this 
purpose, three production clones were cultivated in the BioLector 
microbioreactor (high-throughput bioreactor system from m2p-
labs) using flower-shaped well plates for microbial fermentation 
(1.5 ml working volume). The production clones were provided 
by the research groups of Prof. Martin Bachmann and Prof. 
Martin Sievers. The accompanying process analysis included: 
recording of OD
600
 values (BioSpectrometer Kinetic 6136), 
measurement of selected substrates/metabolites (CedexBio 
V2.3.0, Roche Diagnostics), determination of VLP quantity by 
SDS-Page and ELISA, and the assessment of VLP quality by 
electron microscopy.
In terms of biomass production, as well as VLP quantity and 
VLP quality, the complex 2-YT medium (Sigma-Aldrich) and 
the chemically defined medium according to Riesenberg et al.[4] 
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showed the best results. Both media were used in subsequent 
shake flask studies (using 250 and 500 ml baffled shake flasks 
and the KuhnerTOM online gas analyzer) and modified for fed-
batch applications (feeding). The codon optimized clone (clone 
no. 3) was found to give the highest product concentrations 
in the soluble supernatant and was therefore selected for the 
bioreactor experiments in the ambr 250 modular from Sartorius 
(Fig. 1) and the BIOSTAT D-DCU D-30-3 (Sartorius). The ambr 
experiments indicated a strong dependence of VLP concentration 
on the length of the production phase and the feeding regime 
implemented in the production phase. Thus, to ensure high VLP 
concentrations, excess of carbohydrates was to be avoided. In 
the ambr 250 modular as well as in the BIOSTAT D-DCU D-30-
3, the highest VLP concentrations were obtained using 2-YT 
medium. Although the maximum OD
600
 values (261.2) and total 
VLP concentrations (2.55 g l–1) of the ambr 250 bioreactor runs 
were not achieved, the two proof-of-concept cultivations realized 
in the BIOSTAT D-DCU D-30-3 demonstrated the scalability of 
the developed upstream processing method for SARS-CoV-2 
VLP production.
Filters for Full-protective Suits§
When the SARS-CoV-2 virus started spreading in 
Switzerland, a team at ZHAW was already working on 3D 
nanofiber-based aerosol filters. These filters are an integral part 
of an active ventilated protective suit (Fig. 2a). The project is 
funded by Innosuisse.[5] Such protective suits were developed 
in response to previous pandemics, in particular the Ebola virus 
epidemic in 2014. The personal protective equipment should 
allow healthcare workers to treat patients while being fully 
protected themselves. A key factor is the simple handling of 
the protective gear; (i) since it needs to be donned correctly and 
(ii) during undressing contaminated outside surfaces must not 
be touched. Basic requests are high air circulation to limit the 
associated heat burden and an effective filter against pathogens 
with low-pressure drop. To fulfil these opposing requirements, 
filters are often made of several layers of different materials, 
some of which contain extremely thin nanofibers.
Aerosol filters are not simple sieves as several filtration 
mechanisms take place when submicron aerosols are trapped 
through fibrous media. These include inertial impaction, 
interception, diffusion, and electrostatic attraction. Inertial 
impaction, which happens when the particle cannot follow the 
air flow-field around the fibers, is mostly relevant for particles 
>1 µm because of their higher inertia. Smaller particles that 
Fig. 1. ambr 250 modular used for the first scale-up step of the 
upstream processing of SARS-CoV-2 VLP production in the technology 
room of ZHAW’s Center for Biochemical Engineering and Cell 
Cultivation Techniques (Photo: Patrick Cipriani)
are following the air streamline are caught through interception 
if they come within one particle radius of a fiber. Particles 
smaller than 0.2 µm such as viruses exhibit significant 
Brownian motion and, thus, they no longer follow the air 
streamline. Indeed, they diffuse throughout the filter media 
until they touch a fiber surface. Diffusion capture becomes 
more effective with increasing filter surface and increasing 
retention time. At a given air flow, the retention time can be 
increased by extending the path length of the air stream through 
the filter media. In previous studies, we have investigated 
this effect by converting essentially flat 2D nanofiber mats 
(Fig. 2c) into extremely porous ultralight 3D nanofiber-based 
media, so-called nanofiber sponges or nanofiber aerogels 
(Fig. 2b).[6] Using the right processing conditions, we can 
tune the fiber density and pore size of these 3D filter media. [7] 
With a thickness of 1 cm and a density of 8.7 mg ml–1, such 
materials achieved up to 99.998% filtration efficiency with an 
acceptable permeability of 57.7 × 10–12 m2.[8] We can increase 
the permeability by increasing the pore size, but as with other 
filter media at the cost of filtration efficiency. While previous 
materials were made from biopolymers such as pullulan 
blended with poly(vinyl alcohol), filters in the current project 
are made from synthetic polymers such as polyacrylonitrile 
or polyamide. Filtration efficacy tests are performed at Spiez 
Laboratory (Fig. 2d).
To further direct the development of these next-generation 
nanofiber-based filter media, numerical simulations are 
performed. These simulations start from the actual filter 
geometries as derived from SEM images and µCT measurements 
(Fig. 2e). We are developing our own simulation environment, 
where the propagation of individual particles through the complex 
fibrous geometry is simulated by considering the stochastic 
Brownian dynamics and the forces governing particle-fiber 
interactions such as drag, friction, lift and adhesive forces. This 
approach gives more flexibility and control over the chemico-
physical system parameters, although it requires significant 
simplifications. Simultaneously, we are also testing a voxel-
based CFD commercial software to simulate more complex and 
realistic geometries.[9] Currently, we are calibrating the physical 
model with real experimental data. In the near future, we will be 
able to predict the influence of changes of the 3D arrangement 
of the nanofibers within the filter media in terms of filtration 
Fig. 2. Active ventilated protective suit (a) with integrated 3D nanofiber 
based filter (b); nanofiber production (c); fractional separation efficiency 
with most penetrating particle size (MPPS) and SEM image (d) and 
reconstructed 3D structure based on µCT scans (e) of such filters.
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efficiency and pressure drop. The ultimate challenge will be 
the industrialization of the filter production, but first estimates 
using current technology indicate manufacturing costs of CHF 
10–20 per filter.
Antiviral and Antibacterial Effects of a  
New Self-disinfecting Textile
The use of mouth and nose covering textiles during the 
COVID-19 outbreak has become commonplace. Textiles act as 
mechanical filters and they may be equipped with passive antiviral 
coatings. Here we report on the development of textiles[10] that 
actively and efficiently inactivate viruses and bacteria within 
minutes by application of a few volts. This involves research 
along (i) efficacy: develop and apply a protocol to measure the 
efficacy of microbial inactivation; (ii) safety: assess whether such 
products can be used without safety concerns; (iii) materials: 
selection, tuning and assembly of electrochemical textiles to 
optimize (i) and (ii).
Efficacy
Measurement of the efficacy of inactivation as a function 
of different parameters, applied to a range of viruses and 
bacteria is central to optimize and document the performance 
of antimicrobial textiles for various applications. In the initial 
assays, bacteriophage MS2 (DSM 13767), which is a single-
stranded RNA coliphage, was used as indicator virus together 
with its host, the bacterium Escherichia coli (DSM 5695) as 
indicator bacterium. Bacteriophages are known to have stronger 
survival capability than most human pathogenic viruses and MS2 
has been suggested to be used as a model organism for respiratory 
viruses in certification experiments to assess the potential of 
tissue membranes to inactivate viruses.[11] Requirements and test 
methods for antiviral textiles are described in the ISO 18184 
standard for the determination of the antiviral activity of textile 
products. Next to the already established MS2 phage, also other 
viruses such as the feline calicivirus will be tested, in order to 
establish a standardized and fully validated test protocol for 
routine assessment of antiviral properties of textiles.
Table 1 documents the results for a series of efficacy 
measurement for textiles which combines passive inactivation 
via surface coating as well as active inactivation via application 
of a small voltage. The presently investigated textiles have 
demonstrated a faster and higher antiviral efficacy compared to 
passive antiviral textiles currently on the market. Further, the first 
commercial version (Osmotex Steriliser) is able to show >95% 
virus inactivation in 15 minutes and >99% in 2 hours, when 
applying the established protocol using MS2 phages developed 
at the ZHAW.
Fig. 3. The emissions for a large number of volatile organic compounds 
(VOCs) and hazardous gases from textiles were monitored in real time 
with (a) PTR-ToF-MS and electrochemical sensors (b) - here only a 
selection is shown. In this particular experiment, the pre-wetted textile 
was activated with 3 V direct current for 95 minutes in a closed box 
to document the safety of the voltage application and to demonstrate 
that no increase of VOCs or NO2 and O3 during voltage application was 
detected. (c) Structure and outline of the functionality of electrically 
controlled textiles for on-demand, self-disinfecting textiles for 








Passive antiviral mask 1
(benchmarking 2, commercially available)
 15 109 77 ± 58
Passive antiviral mask 2
(benchmarking 2, commercially available)
 15 109 87 ± 43






Osmotex Steriliser high performance materi-
al (not commercially available)
 15
109
> 99.9997 ± 0.0007 (not a 
single active virus could be 
observed after test)
Osmotex Steriliser mask prototype 120 107 99 ± 1
Table 1. Results for different tex-
tiles that were tested with antiviral 
test protocols. These included 
the Osmotex Steriliser techno-
logy (first commercial textiles to 
be used in face masks) as well 
as passive sterilizing textiles, 
which are commercially availa-
ble as masks, for benchmarking 
(measurement uncertainty: 95% 
confidence interval).
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Conclusion
In the meantime, the development of SARS-CoV-2 vaccine in 
Switzerland was stopped, but the significance of bio manufacturing 
is still present. Full protective suites are not limited to SARS-
CoV-2 and smart sterilization may become an important tool in 
fighting daily health issues such as the flu, MRSA, and other 
hospital acquired infections.
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Safety
The targeted sterilization effect requires a controlled 







, which is voltage- and time-dependent. While ROS have 
to be tuned to achieve the desired efficacy, they also need to 
be monitored and quantified. Furthermore, one has to monitor 
the formation and emission level of potentially harmful 
volatile organic compounds (VOCs) that might be generated 
during the application of a voltage. Accordingly, an analytical 
platform was developed to monitor the time- and space-
dependent production and emission of ROC and VOCs from 
textiles. Knowledge of spatial emission patterns is crucial for 
improving the surface sterilization effect. Therefore, a sampling 
setup was established through coupling and adapting analytical 
technologies for the measurement of the volatile ROS and 
VOCs. Analytical techniques for VOC analysis include gas 
chromatography mass spectrometry for targeted identification 
and quantification of VOCs and proton-transfer-reaction time-
of-flight mass spectrometry (PTR-ToF-MS) for time-resolved 
high-sensitivity untargeted analysis,[12] as shown in Fig. 3a. To 





several electrochemical gas sensors have been used to detect 
potential gas emission in the ppb range, Fig. 3b. In addition, 
spectrometric methods are being deployed for quantitative 
analysis of hydrogen peroxide in solution.
Material
The basic design of first-generation textiles being developed 
consists of a three-layered design, see Fig. 3c; an insulating 
membrane between two conductive layers. An electrical voltage 
of 0.5 up to a few volts is applied via a rechargeable battery. 
In combination with humidity and air/oxygen, ROS are formed 
in the aqueous phase. Once these ROS come into contact with 
viruses on the textile, viruses (and bacteria) are destroyed 
within a few minutes. 
The desired properties of the separator materials are ionic 
conductivity at low water content, facile wetting, elimination 
of the risk of direct contact between electrodes, low costs and 
flexibility. Textile electrodes should provide high conductivity, 
fine mesh, textile-like tactile feeling, moister withholding 
properties and the ability of coating. The contact layer properties 
depend on the properties of the electrode layers. 
For now, a strong active virucidal and bactericidal effect 
was shown for the first generation of these new textiles, within 
minutes and with an efficiency better than 95% (see Table 1). 
The self-disinfecting fabrics will be further optimized and they 
will be used to develop face masks and other commodities 
(bags, coats, seat covers, etc.) with on-demand sterilizing 
functionality, which could help to overcome the burden in 
daily life that is drastically restricted by the SARS-CoV-2 and 
potential future viral pandemics.
